Background and update for ECOG-ACRIN EA8212: A randomized phase 3 trial of intravesical bacillus Calmette-Guérin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naïve high-grade non–muscle-invasive bladder cancer (BRIDGE) Review
| Authors: | Kates, M.; Chu, X.; Hahn, N.; Pietzak, E.; Smith, A.; Shevrin, D. H.; Crispen, P.; Williams, S. B.; Daneshmand, S.; Packiam, V. T.; Porten, S.; Westerman, M. E.; Wagner, L. I.; Carducci, M. |
| Review Title: | Background and update for ECOG-ACRIN EA8212: A randomized phase 3 trial of intravesical bacillus Calmette-Guérin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naïve high-grade non–muscle-invasive bladder cancer (BRIDGE) |
| Keywords: | cancer chemotherapy; controlled study; clinical trial; cancer risk; drug efficacy; note; gemcitabine; cancer grading; bcg vaccine; randomized controlled trial; bladder cancer; bladder tumor; urinary bladder neoplasms; docetaxel; phase 3 clinical trial; administration, intravesical; deoxycytidine; intravesical drug administration; non muscle invasive bladder cancer; humans; human; doxecitine; non-muscle invasive bladder neoplasms |
| Journal Title: | European Urology Focus |
| Volume: | 9 |
| Issue: | 4 |
| ISSN: | 2405-4569 |
| Publisher: | Elsevier B.V. |
| Date Published: | 2023-07-01 |
| Start Page: | 561 |
| End Page: | 563 |
| Language: | English |
| DOI: | 10.1016/j.euf.2023.06.006 |
| PUBMED: | 37422371 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Source: Scopus |
